Self-Injection Market Size, Share, By Product (Needle Free Injectors, Auto injectors, Pen Injectors, and Wearable Injectors), Usability (Disposable, and Reusable), Usability (Cancer, Autoimmune Disorders, Hormonal Disorders, Pain Management, and Others),

Self-Injection Market Size, Share, By Product (Needle Free Injectors, Auto injectors, Pen Injectors, and Wearable Injectors), Usability (Disposable, and Reusable), Usability (Cancer, Autoimmune Disorders, Hormonal Disorders, Pain Management, and Others), End-Users (Hospital, Specialty Clinics, and Others), and Region - Trends, Analysis, and Forecast till 2035

Self-injection is the process of injecting a drug or other substance into the body. Rising number of patient preference toward self-administration, increasing cases of hormonal diseases & cancer cases, availability of affordable self-injections, ongoing R&D activities, rising healthcare expenditure, rising popularity of home treatment, and others are the factors contributing to the self-injection market growth.

Key Benefits of Purchasing This Report

Gain valuable insights into revenue projections for the overall market and its sub-segments, benefiting industry leaders and new entrants.

Enhance your understanding of the competitive landscape to refine business positioning and optimize go-to-market strategies.

Stay informed on the latest trends in the Self-Injection Market, including key drivers, challenges, opportunities, and barriers.

Self-Injection Market Report Highlights:

• By 2035, the market is forecasted to abound at USD 181.4 Billion.
• In 2024, the self-injection market size was at USD 60.67 Billion.
• Target market is accelerating at a CAGR of 12.8%.
• North America held the largest self-injection market share in 2024.
• Asia Pacific is expected to be the fastest-growing region in the market during the forecast period.
• By product, the needle free injectors segment is expected to dominate the market.
• Under usability, disposable is the leading segment in the market.
• Based on application, the cancer segment holds the largest target market share.
• The hospital end-user segment is expected to grow with the highest CAGR during the forecast period.

Self-Injection Market Key Highlights:

In March 2024, according to a recent announcement, the FDA has approved a new single-dose, pre-filled delivery device, named SeflJect injector, to be used for Acthar Gel (repository corticotropin injection; Mallinckrodt), a treatment indicated for various number of chronic and acute inflammatory and autoimmune conditions, including multiple sclerosis (MS).

In April 2021, Novartis announced that the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application for Xolair (omalizumab) prefilled syringe for self-injection in appropriate patients across all approved U.S. indications. 1 Xolair is the only FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic asthma, chronic idiopathic urticaria (CIU) and nasal polyps.

Self-Injection Market Report Analysis:

Steps for Self-Administration of Injection –

• Wash and dry hands with soap and water
• Clean the area of skin you intend to inject with an alcohol wipe
• Hold the syringe in your dominant hand with the barrel of the syringe between your fingers and your thumb on the plunger
• With your other hand pinch an area of skin between your fingers to create a lump
• Insert the needle all the way into the skin
• Press down the plunger while keeping the needle still
• Use the markings on the barrel to give the amount you have been instructed to
• Remove the needle at the same angle
• Dispose of the needle in the sharps box
• Wipe the area with a piece of gauze

Segmentation:

By Product:

• Needle Free Injectors
• Auto injectors
• Pen Injectors
• Wearable Injectors
• Others

By Usability:

• Disposable
• Reusable

By Application:

• Cancer
• Autoimmune Disorders,
• Hormonal Disorders
• Pain Management
• Others

By End Users:

• Hospital
• Specialty Clinics
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• Indonesia
• Malaysia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• GCC
• Israel
• South Africa
• Rest of Middle East & Africa

Self Injection Market Competitive Landscape

• BD
• YPSOMED
• West Pharmaceutical Services, Inc.
• Haselmeier
• NuGen Medical Devices
• Owen Mumford Limited
• SHL Medical
• PFIZER INC.
• Amgen Inc.
• Insulet Corporation
• Halozyme, Inc.
• Apikos Pharma & Penardo Biotech Pvt. Ltd.
• Hindustan Syringes & Medical Devices Ltd.
• GSK PLC

Key Questions Answered in This Report

What was the size of the Self-Injection Market in 2024?

2. What is the expected growth rate of the Self-Injection Market during 2025-2035?

3. What are the key factors driving the Self-Injection Market?

4. What is the breakup of the Self-Injection Market based on the distribution channel?

5. What are the key regions in the Self-Injection Market?

6. Who are the key players/companies in the Self-Injection Market?

7. What are the drivers, restraints, and opportunities in the Self-Injection Market?